These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 35941638)

  • 41. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer.
    Ma XB; Xu YY; Zhu MX; Wang L
    Front Oncol; 2020; 10():591739. PubMed ID: 33680920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Prognostic Model Using Immune-Related Genes for Colorectal Cancer.
    Feng W; Zhang Y; Liu W; Wang X; Lei T; Yuan Y; Chen Z; Song W
    Front Cell Dev Biol; 2022; 10():813043. PubMed ID: 35252182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
    Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
    J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
    Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
    J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of the survival status and tumor microenvironment in colorectal cancer through genotyping analysis based on toll-like receptors.
    Peng H; Zhang J; Yang Z; Chen L; Chen J; Cai C
    Saudi J Gastroenterol; 2024 Jul; 30(4):243-251. PubMed ID: 38813725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatic analysis of RNA-seq data from TCGA database reveals prognostic significance of immune-related genes in colon cancer.
    Ouyang Y; Huang J; Wang Y; Tang F; Hu Z; Zeng Z; Zhang S
    Medicine (Baltimore); 2022 Aug; 101(31):e29962. PubMed ID: 35945793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
    Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
    BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
    Qiu H; Hu X; He C; Yu B; Li Y; Li J
    Front Genet; 2020; 11():12. PubMed ID: 32117435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer.
    Zhang S; Li Z; Dong H; Wu P; Liu Y; Guo T; Li C; Wang S; Qu X; Liu Y; Che X; Xu L
    Sci Prog; 2021; 104(1):36850421997286. PubMed ID: 33661721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response.
    Xiao Y; Gao L; Zhao X; Zhao W; Mai L; Ma C; Han Y; Li X
    Int Immunopharmacol; 2024 Sep; 139():112603. PubMed ID: 39043103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.
    Qin R; Li C; Wang X; Zhong Z; Sun C
    Cancer Cell Int; 2021 Jul; 21(1):378. PubMed ID: 34266418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
    Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
    Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coagulation- and fibrinolysis-related genes for predicting survival and immunotherapy efficacy in colorectal cancer.
    Ma Y; Wang B; He P; Qi W; Xiang L; Maswikiti EP; Chen H
    Front Immunol; 2022; 13():1023908. PubMed ID: 36532065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
    Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
    Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
    Dong M; Cui X; Wang G; Zhang Q; Li X
    Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A CLRN3-Based CD8
    Gong Z; Huang X; Cao Q; Wu Y; Zhang Q
    Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.